Consent to participate in an Online Research Study
This notice is for an AUB-IRB Approved Research Study
for Dr Elie Akl at AUB
*It is not an Official Message from AUB*
In the context of the COVID-19 pandemic, the World Health Organization (WHO) is developing a rapid advice guide on the appropriate use of radiological imaging in patients with COVID-19. Recommendations will be provided regarding chest imaging procedures (including chest X-Ray, computer tomography (CT) scan, ultrasound (US)) in different clinical scenarios. In preparation for that guide, systematic reviews are being conducted to inform evidence-based guidance on COVID-19. To complement this work, you are invited to participate in the present survey that has been developed to gather the views of stakeholders to (i) rate the outcomes, and (ii) judge the acceptability, feasibility, impact on equity, and resource use for the different imaging modalities.
The results of the survey will be provided in a summary table for consideration in WHO’s rapid advice guide. They will also be submitted in the form of an article for publication in a relevant scientific journal.
The survey is conducted by Dr Elie Akl at the American University of Beirut (AUB) in coordination with the WHO. The conduct of this study will adhere to the Institutional Review Board (IRB) approved protocol. The IRB approved method for approaching subjects is through a cross-sectional online survey.
We invite you to read the below and consider whether you want to be involved in the survey. Please note:
- Participation is completely voluntary.
- Completing the questionnaire will take around 15 minutes.
- Only the data you provide in the questionnaire will be collected and analyzed. The research team will not have access to your name or contact details.
- The inclusion criteria: individuals with stakes into the implementation of the planned advice guide. These stakeholders include patients and their caregiver/family, healthcare professionals, policymakers, and others.
- The exclusion criteria: individuals younger than 18 years old.
Potential benefits and risks to subjects and/or to society
You will not receive payment for participation in this study. The results of the study will complement the systematic reviews that are being conducted to inform evidence-based guidance by the WHO on imaging modalities in COVID-19. The risks of the survey are minimal.
The collected data will remain confidential and anonymous. Records will be monitored and may be audited by the IRB while assuring confidentiality.
Participation and withdrawal
If you voluntarily consent to take part in this survey, you can change your mind and withdraw at any time without consequences of any kind.
Refusal to participate or withdrawal from the survey will involve no penalty or loss of benefits to which the subject is otherwise entitled, and neither will it affect their relationship with their organization and AUB/AUB-Medical Center.
Questions about the survey
If you have any questions about the survey, you can contact the research team at firstname.lastname@example.org, Dr Elie Akl.
Concerns or questions about your rights
If you have concerns about the survey or questions about your rights as a participant, you can contact the AUB IRB Office:
Telephone: 00961 -1-350000 or 1 374374, ext: 5445
Fax: +961 1 738025
PO BOX: 11-0236 F15, Riad El Solh, Beirut 1107 2020, Lebanon
If after reading this consent document and having your questions answered, you voluntarily agree to take part in the study; you can access the survey by pressing ‘NEXT’.